Literature DB >> 10514242

Myasthenia gravis, thymoma, intestinal pseudo-obstruction, and neuronal nicotinic acetylcholine receptor antibody.

R Pande1, A A Leis.   

Abstract

Intestinal pseudo-obstruction occurs rarely in patients with myasthenia gravis (MG) and thymoma. The etiology of the intestinal pseudo-obstruction remains to be elucidated, although an autoimmune mechanism is postulated. We present the first report of neuronal nicotinic acetylcholine receptor (AChR)-specific antibody in a patient with seropositive MG, malignant thymoma, and intestinal pseudo-obstruction. This finding provides evidence that intestinal pseudo-obstruction associated with thymoma and possibly other neoplasms may be related to antibodies against the neuronal nicotinic receptors at autonomic ganglia. Copyright 1999 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10514242     DOI: 10.1002/(sici)1097-4598(199911)22:11<1600::aid-mus19>3.0.co;2-3

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  4 in total

Review 1.  Enteric autoantibodies and gut motility disorders.

Authors:  Purna Kashyap; Gianrico Farrugia
Journal:  Gastroenterol Clin North Am       Date:  2008-06       Impact factor: 3.806

Review 2.  New perspectives in the diagnosis and management of enteric neuropathies.

Authors:  Charles H Knowles; Greger Lindberg; Emanuele Panza; Roberto De Giorgio
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-02-12       Impact factor: 46.802

3.  Does cardiovascular autonomic dysfunction contribute to fatigue in myasthenia gravis?

Authors:  A Elsais; E Kerty; K Russell; K Toska
Journal:  Physiol Res       Date:  2022-01-19       Impact factor: 1.881

4.  Adhesive ileus complicating recurrent intestinal pseudo-obstruction in a patient with myasthenia gravis.

Authors:  Charalampos Seretis; Fotios Seretis; George Gemenetzis; Stavros Gourgiotis; Emmanuel Lagoudianakis; Apostolos Pappas; Dimitrios Keramidaris; Nikolaos Salemis
Journal:  Case Rep Gastroenterol       Date:  2012-06-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.